| NCT ID | NCT07316894 |
| Status | Recruiting |
| Phase | — |
| Sponsor | ELIAS Emergency University Hospital |
| Condition | Iatrogenic Withdrawal Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2025-12-13 |
| Primary Completion | 2026-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2025-12-13 with a primary completion date of 2026-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is an International Delphi Consensus on the Definition and Diagnosis of Iatrogenic Withdrawal Syndrome in adult critically ill patients. It involves the anonymous completion of a questionnaire using a 7-point Likert scale.
Eligibility Criteria
Inclusion Criteria: * At least 5 years of experience or training or research in the field of Intensive Care Medicine, Anesthesiology or Psychiatry Exclusion Criteria: * Not a specialist in the fields of Intensive Care Medicine, Anesthesiology or Psychiatry
Frequently Asked Questions
Who can join the NCT07316894 clinical trial?
This trial is open to participants of all sexes, studying Iatrogenic Withdrawal Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07316894 currently recruiting?
Yes, NCT07316894 is actively recruiting participants. Visit ClinicalTrials.gov or contact ELIAS Emergency University Hospital to inquire about joining.
Where is the NCT07316894 trial being conducted?
This trial is being conducted at Bucharest, Romania.
Who is sponsoring the NCT07316894 clinical trial?
NCT07316894 is sponsored by ELIAS Emergency University Hospital. The trial plans to enroll 120 participants.